Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE)
Title:
Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE)
Author:
Campani, C. Vitale, A. Dragoni, G. Aburas, S. Arena, U. Laffi, G. Cillo, U. Giannini, E.G. Trevisani, F. Marra, F.